Stocks and Investing Stocks and Investing
Tue, February 20, 2024

Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $165 on, Feb 20th, 2024


Published on 2024-10-28 09:04:27 - WOPRAI, Olivia Brayer
  Print publication without navigation


Olivia Brayer of Cantor Fitzgerald, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $165 on, Feb 20th, 2024.

Olivia has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 5 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $173 on, Friday, February 16th, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Hold with Decreased Target to $161 on, Friday, February 16th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Hold on, Thursday, February 15th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $176 on, Tuesday, February 13th, 2024
  • Jessica Fung of "JP Morgan" Maintained at Hold with Increased Target to $170 on, Thursday, February 1st, 2024


These are the ratings of the 5 analyists that currently disagree with Olivia


  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $227 on, Friday, February 16th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $225 on, Friday, February 16th, 2024
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $200 on, Thursday, February 15th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Friday, December 15th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $217 on, Thursday, December 14th, 2023
Contributing Sources